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Background: Necroptosis is an important mode of cell death, which is due to oxidant stress accumulation. Our
previous study indicated that oxidant stresses could be reduced by Timosaponin B-II (TBII), a kind of Chinese herb
RhizomaAnemarrhenae monomer extraction. We wonder the possible effect of Timosaponin B-II, whether it can
protect cells from necroptosis via reducing the oxidant stress, in RGC-5 following hydrogen peroxide (H2O2) insult.
Methods: RGC-5 cells were grown in DMEM, the model group was exposed in H2O2 with the concentration of
300 μM, and the experimental group was pre-treated with Timosaponin B-II at different concentrations (1 μM,
10 μM, 100 μM and 1000 μM) for 24 hrs. MTT assay was carried out to measure the cytotoxicity of H2O2, MDA
concentration assay was executed to evaluate the degree of oxidative stress, TNF-α ELISA Assay was used to
measure the concentration of TNF-α, finally, the degree of necrosis were analyzed using flow cytometry.
Results: We first constructed the cell injury model of necroptosis in RGC-5 upon H2O2 exposure. Morphological
observation and MTT assay were used to evaluate the degree of RGC-5 death. MDA assay were carried out to
describe the degree of oxidant stress. Annexin V/PI staining was used to detect necroptotic cells pre-treated with or
without Timosaponin B-II following H2O2 injury. TNF-α ELISA was carried out to detect the TNF-α accumulation in
RGC-5. Upon using Timosaponin B-II with concentration of 100 μM, the percentage of cell viability was increased
from 50% to 75%, and the necrosis of cells was reduced from 35% to 20% comparing with H2O2 injury group.
Oxidant stress and TNF-α was reduced upon injury which decreased the ratio of RGC-5 necroptosis.
Conclusion: Our study found out that Timosaponin B-II might reduce necroptosis via inhibition of ROS and TNF-α
accumulation in RGC-5 following H2O2 injury.
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Necroptosis is a novel kind of cell death which has simi-
lar morphological features of necrosis [1,2]. The previ-
ous studies pointed out that necroptosis was usually
initiated by TNF-α or FasL, etc. and transmitted by cer-
tain specific cytokines, which results in the accumulation
of oxidative products and eventually leading to necrosis.
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unless otherwise stated.specific inhibitor of necroptosis) [1]. Necroptosis existed
in different cell types, such as epidermal keratinocytes
[3], Jurkat T cells [4], L929 cells [5,6], HepG2 cells [7],
hippocampal neurons [8], cortical neurons [9] and
photoreceptor cells [10], etc. upon injury. Furthermore,
Rosenbaum, et al. have found a large number of necrotic
cells exist in rat retinal ganglion cell layer by PI staining
at the early stage of acute high intra-ocular pressure
(aHIOP) [11]. The numbers of PI-positive neuron de-
creased, and the "b" wave was partially restored in flash
ERG with Nec-1 pretreatment. Dvoriantchikova’s recent
works showed that retinal ganglion cells (RGCs) necrop-
tosis promoted in aHIOP-induced retinal damage [12],td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[13]. Additionally, our recent studies have also indicated
that necroptosis occurs in retinal ganglion cells-5 (RGC-
5) at an early stage following elevated hydrostatic pres-
sure (EHP) in vitro [14] or hydrogen peroxide (H2O2)
treatment (our unpublished data) detected by flow cy-
tometry (a typical way to monitor necroptosis) [15].
Although some scientists recently have synthesized
necroptosis inhibitors, such as Nec-3 [16], Nec-5 [17],
Nec-7 [18], Nec-21 [19], etc., the mechanism still needs
to be further clarified. Nec-1 is a synthetic small mo-
lecular compound which is the most commonly used in
necroptosis inhibition [1]. So far, there are no reports
about whether it has side effects when it is applied to
animal or cellular models. Traditional Chinese herb rhi-
zomaanemarrhenae is the dried rhizome of anemarrhe-
naasphodeloidesbge. It contains lots of steroidal saponins
including sarsasapogenin, markosapogenin, negitogenin,
diosgenin and its glycosylated derivatives, like Timosapo-
nin A-I, A-II, A-III, A-IV, B-I, B-II,C, D and Timosa-
ponin E [20]. Li [21] indicated that Timosaponin B-II
(Figure 1, the chemical structure of Timosaponin B-II,
CAS number: 136656-07-0) might improve the impair-
ment of learning and memory caused by cerebral ische-
mia in a dose-dependent manner. Lu [11] and Kim’s [22]
research suggested that, Timosaponin B-II could not
only inhibit the production of IL-1β and IL-6, but also
TNF-α (one of important molecules which initiates
necroptosis), these results suggested the effect might be
related to Timosaponin B-II which has anti-inflammatory
activity. Besides, Zhang [23] and Kaname [24] found
Timosaponin E-I, E-II, B-II, B-III and A-III played an im-
portant role in superoxide dismutase-generation. Deng
[25] demonstrated that culturing primary rat neurons
(Aβ25–35 insult model) with Timosaponin B-II at a certain
range of concentrations showed remarkable anti-oxidative
damage effects, which indicated Timosaponin B-II could
remove oxygen radicals, and keep the intra-cellular redox
reactions in a dynamic equilibrium [26]. Our previous
study also showed that Timosaponin B-II participated
in the protection of rat RGCs which was treated by
FeCl3 solution via anti-oxidation [27]. Of note, whetherFigure 1 The chemical structure of Timosaponin B-II.Timosaponin B-II could inhibit oxidative stress-induced
RGCs necroptosis or not, it is still under investigation.
Therefore, our present experiments focused on Timosa-
ponin B-II’s potential roles in RGC-5 necroptosis sup-
pression upon hydrogen peroxide (H2O2) treatment.
Meanwhile, the effect of Timosaponin B-II on malon-
dialdehyde (MDA, biomarker of oxidative stress) and
TNF-α in RGC-5 has been investigated. Our study may
give a better understanding of the protective effect of
Timosaponin B-II upon neuronal injury, and provide




The mouse retinal ganglion cell line (RGC-5) was con-
tributed by Department of Ophthalmology, Second Hos-
pital of Ji Lin University, China [28]. RGC-5 cells were
grown in Dulbecco’s Modified Eagle Medium (DMEM,
HyClone Laboratories, Inc. UT, USA) and supplemented
with 10% fetal bovine serum (FBS, HyClone Laborator-
ies, Inc. UT, USA), 100 U/ml of penicillin and 100 μg/ml
of streptomycin (HyClone Laboratories, Inc. UT, USA).
The RGC-5 cells used in the experiment were with 2-3
passages post-thawed to minimize the variability in the
assays based on our observations. The density of RGC-5
cells was around 80% in 6 ml culture media in 50 ml
flask before insults (H2O2 treatment).
Reagent
The powder of Timosaponin B-II was provided by Profes-
sor Wan-Sheng Chen from Department of Pharmacology,
School of Pharmacology, Second Military Medical Univer-
sity, Shanghai, China [29,30] and its purity is above 98%.
Timosaponin B-II was dissolved in sterile normal saline
(NS) at 2 mM in room temperature (24°C), H2O2 (Sigma-
Aldrich, MO, USA) with 0.01 M PBS at 3 mM in store to
yield a low concentration working solutions.
Cell model construction and drug treatment
Cells were equally divided into three groups randomly.
The normal control group (CTL), the model group (H2O2,
300 μM), and the experimental group (H2O2 + Timosapo-
nin B-II). The experimental group was pre-treated with
Timosaponin B-II at different concentrations (1 μM, 10
μM, 100 μM and 1000 μM) for 24 hrs. No drugs were ex-
posed to the normal control or the model group. After
that, we used H2O2 of 300 μM for 12 hrs to get cell insult
and randomly selected three in each group for morpho-
logical studies while the remaining cells were used for bio-
chemistry studies. For morphological study, the pictures
of the attached cells were captured using inverted micro-
scope in 10 × objective (Olympus, CKX41, Tokyo, Japan).
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selected the typical graphics to illustrate.MTT assay
Cytotoxicity of H2O2 model group and Timosaponin B-
II pretreated group (1 μM, 10 μM, 100 μM and 1000
μM) were assessed in RGC-5 cells by measuring the
amount of insoluble formazan formed in live cells based
on the reduction of 3-(4, 5 dimethylthiazol-2-yl)-2,
5-diphenyltetrazolium bromide (MTT) salt (Nanjing
Jian-Cheng Bio-engineering Institute, Jiangsu, China)
according to the manufacturer's protocol. The cells were
seeded in 96-well plates with a density of 104 cells/well
incubated for 24 hrs at 37°C and 5% CO2. The cells were
pretreated with different concentrations of Timosaponin
B-II before H2O2 insult or H2O2 used alone and PBS as
a negative control. Within 24 hrs pre-treatment of
Timosaponin B-II, 50 μl of MTT labeling reagent (2 μg/
ml) was added to each well. The plates were incubated
at 37°C in a humidified atmosphere with 5% CO2 for 4
hrs. Thereafter, 100 μl of the solubilization solution was
added to each well and followed by incubation overnight
at 37°C to dissolve formazan crystals. Absorbance was
ultimately read using an ELISA plate reader (Bio-tek,
ELx800, IL, USA) at a wavelength of 570 nm. Where,
H2O2 model group and Timosaponin B-II pretreated
group are mean absorbance of treated cells and negative
control, respectively.MDA concentration assay
MDA levels in RGC-5 extractions were assayed using a
commercial kit according to manufacturer’s instructions
(Nanjing Jian-Cheng Biotechnical Co., Jiangsu, China)
as in our previous study [27], the standard reference
substance named tetraethoxypropane were used in 10
nmol/ml. Equal quantities (100 μg) of protein were
loaded in each well and each analysis performed in
duplicate.TNF-α ELISA assay
A RGC-5 TNF-α concentration assay was performed
using a commercial TNF-α ELISA kit (Invitrogen, CA,
USA). The detailed processes were conducted according
to the manual included in the kit. Positive control: the
antibody tested in the kit was replaced by mouse TNF-α
(provided in assay, concentration: 720 ng/L). Equal
quantities of protein (80 μg) were analyzed in every
tested well and the measurements were carried out by
Bio-tek microplate-reader (ELx800, IL, USA). The per-
centage of TNF-α concentration in normal control
group was set as 100%. All experiments were repeated
at least twice.Flow cytometry
The cells attached to the flasks were trypsinized followed
by a gentle wash. The experimental group was pre-
treated with Timosaponin B-II at 100 μM. The model
group was treated with H2O2 at 300 μM. Resuspended
the cells in 200 μl of 1× binding buffer, and then added
5 μl of 20 μg/ml Annexin V and 10 μl of 50 mg/ml PI,
incubated at RT for 15 mins in the dark. After the cells
were washed and analyzed by FACS Calibur (Becton,
Dickinson Company, NJ, USA). The percentages of cells
in each quadrant were analyzed using ModFit software
(Verity Software House Topsham, NJ, USA). Statistical
results of flow cytometry were conducted by calculating
the PI+ cells numbers. All the results were repeated
three times.
Data analysis
Figure panels were assembled by using Photoshop CC
(Adobe, CA, USA). The data were analyzed by using
SPSS 19.0 (SPSS, IL, USA). One-way analysis of variance
(one-way ANOVA) was performed to test differences in
average value between groups. All results were presented
as mean ± SD. A value of p < 0.05 was considered statisti-
cally significant.
Results
Timosaponin B-II could protect RGC-5 from H2O2 injury
The normal RGC-5 cell graphic were shown in Figure 2A.
The cells grew in apposite density and adherent well
with axon-elongated and interweave each other to be a
mesh, each of them presented as identical size and con-
sistent morphology. The number of the cells decreased
in H2O2 injury group (Figure 2B), and plenty of them
were detached and floated in culture media. As shown
in Figure C-E, the number of adherent cells increased
following the incubated concentration of Timosaponin
B-II increase, it is worth noting that the number of
adherent cells in 1000 μM Timosaponin B-II treatment
group is less than those in 100 μM Timosaponin B-II
treatment group (Figure E and F). These results indicated
that Timosaponin B-II could protect RGC-5 from H2O2
insult yield to the concentration manner, but the effect
may reverse with higher concentrations of Timosaponin
B-II in 1000 μM.
Timosaponin B-II could increase RGC-5 viability upon
H2O2 injury
In order to evaluate the viability of RGC-5 in model group
and Timosaponin B-II treatment group, we carried out
MTT assay to detect cell viability. The statistical analysis
of MTT result was shown in Figure 3. Comparing to nor-
mal control group (CTL), the cell viability was significantly
decreased in model group and Timosaponin B-II treat-
ment group. The cell viability kept gradually increasing
Figure 2 The morphological graphic of RGC-5 cell line insult with H2O2 after 12 hrs pretreating in different concentration of TBII by
inverted microscope; A: Normal Control; B: Model group (H2O2 treatment); C: TBII pretreatment group (H2O2 + 1 μM TBII); D: TBII
pretreatment group (H2O2 + 10 μM TBII); E: TBII pretreatment group (H2O2 + 100 μM TBII); F: TBII pretreatment group (H2O2 + 1000
μM TBII), Scale bar = 100 μm in A-E.
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cept 1000 μM Timosaponin B-II group. These results indi-
cated that Timosaponin B-II could rescue RGC-5 viability,
which was impaired by the H2O2.Timosaponin B-II reduced MDA production in RGC-5
The statistical analysis of MDA level is shown in Figure 4.
The level of MDA in the experimental group (except 1000
μM Timosaponin B-II treatment group) kept decreasing
Figure 3 The percentage of MTT in RGC-5 cell line insult with
H2O2 after 12 hrs pretreating in different concentration of TBII
(Normal Control were set as 100%). **vs CTL: p < 0.01; #vs Model
group: p < 0.05; *vs CTL: p < 0.05.
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after increasing the concentration of Timosaponin B-II,
but it remained at higher level than those in normal con-
trol group (CTL). In 100 μM Timosaponin B-II treatment
group, the level of MDA decreased significantly compared
with H2O2 insult group (p < 0.05). These results indicated
that Timosaponin B-II reduced the oxidative stress which
is usually induced by H2O2 in RGC-5. Nevertheless, the
capacity of anti-oxidant was limited, because the oxidative
stress remained higher than normal control group in
Timosaponin B-II treatment group.Figure 4 The concentration of MDA in RGC-5 cell line insult
with H2O2 after 12 hrs pretreating in different concentration of
TBII. **vs CTL: p < 0.01; #vs Model group: p < 0.05; *vs CTL: p < 0.05.Timosaponin B-II inhibited TNF-α production in RGC-5
The statistical analysis of ELISA assay for TNF-α level
was described in Figure 5. The level of TNF-α in the ex-
perimental group (except 1000 μM Timosaponin B-II
treatment) was gradually decreasing compared to the
model group after increasing the concentration of
Timosaponin B-II, but it remained at higher levels com-
pared to those in normal control group. These results
indicated that Timosaponin B-II remarkably inhibited
TNF-α production. Nevertheless, the effect of Timosa-
ponin B-II was impaired to a certain extent since the
level of target peptides was still higher than those in
normal condition.
Timosaponin B-II may decrease the rate of RGC-5 necrosis
Upon 300 μM H2O2 insult, necrosis in RGC-5 oc-
curred in our study. Therefore, the cells were treated
under this condition with the addition of Timosaponin
B-II at different concentrations. After that, we ana-
lyzed cellular necrosis by using flow cytometry with
PI/Annexin V double staining, and detected whether it
could decrease the rate of necrosis in RGC-5 with pre-
treatment of Timosaponin B-II upon H2O2 insult.
These results showed that the ratio of necrosis cells is
30.3% (Figure 6B), the percentage decreased to 22.8%
upon adding Timosaponin B-II (100 μM, Figure 6C).
Meanwhile, statistical analysis indicated that there
were significant changes in the rate of PI-positive
RGC-5 in Timosaponin B-II pretreatment group com-
pared with normal control group and H2O2 model
group (Figure 6D). These results indicated that RGC-5
necroptosis in the early stage may decrease with
Timosaponin B-II usage.Figure 5 The percentage of TNF-α concentration in RGC-5 cell
line insult with H2O2 after 12 hrs pretreating in different
concentration of TBII. **vs CTL: p < 0.01; #vs Model group: p < 0.05; *vs
CTL: p < 0.05.
Figure 6 The flow Cytometry analysis of RGC-5 cell line insult with H2O2 after 12 hrs pretreating in different concentration of TBII. A:
Normal Control; B: Model group (H2O2 treatment); C: TBII pretreatment group (H2O2 + 100 μM TBII); D: Statistical analysis; *vs CTL: p < 0.01;
#vs
Model group: p < 0.01.
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At present, mechanism of cell death is one of the hot-
spot in the field of life science research. As far as we are
concerned, compared to apoptosis and autophagy, the
researchers did not pay enough attention to necrosis due
to the traditional viewpoint that it cannot be modulated
and intervened. Necroptosis is the latest cell death mode
which was conceptualized in last century in mid-1980s
[31]. Since then, it started to catch more and more at-
tention [32-34]. We speculate that damaged cells could
be rescued if necroptosis can be intervened at an early
stage, and it will also help us find a better strategy for ra-
tional interventional therapy in the future.
Chinese herb has a wealth of resources from natural ma-
terials with lower side effects, more economical and other
advantages, etc. However, it also has the disadvantages
such as its complicated composition which cannot be
identified easily. Timosaponin B-II is a monomer which
is extracted from Chinese herb rhizomaanemarrhenae,
it has multiple pharmacological effects, including anti-
inflammatory [21,35], anti-diabetic [36], anti-oxidative
stress [23,26,27], anti-senile dementia [37], learning
ability or memory improvement [21] and neuro-
protection [27] or anti-apoptosis effect in human umbil-
ical vein endothelial cells [38], etc. Our MTT assay re-
sults showed that viability of RGC-5 in model group
(H2O2 treatment) was significantly decreased, while
RGC-5 was pre-incubated by Timosaponin B-II (1 μM,
10 μM and 100 μM groups) for 24 hrs, RGC-5 prolifera-
tion increased gradually in a dose-dependent manner.
The RGC-5 proliferation of 100 μM treatment group
reached a peak, but it significantly decreased in 1000
μM treatment group. The morphological results sug-
gested that the number of RGC-5 decreased remarkably
in model group, the survival of cells tends to be similar
as MTT when pretreated with Timosaponin B-II. Taken
all together, it indicated that Timosaponin B-II played a
protective role on RGC-5 in H2O2-induced damage
under a certain concentration. In addition, our results
in flow cytometry showed that the number of RGC-5
cell necrosis significantly reduced in 100 μM Timosaponin
B-II pretreated group, which suggested that Timosaponin
B-II may be partly involved in inhibiting RGC-5 necropto-
sis under H2O2 exposed conditions. Moreover, our results
on oxidation products measurement also showed that
Timosaponin B-II could significantly decrease the accu-
mulation of MDA in RGC-5 in certain range of con-
centrations. Furthermore, we had observed that TNF-α
was also inhibited in Timosaponin B-II pretreatment
group. Considering one of the most important pathways
in necroptosis (TNF-α induced necroptosis pathway
initiate-----necroptosis related molecular modulation-----
ROS accumulation------cell necrosis [39,40]), we specu-
lated that Timosaponin B-II might inhibit the RGC-5necroptosis by reducing oxidation products and TNF-α
level.
Finally, it is worthy of noting that our experiments re-
vealed the following two questions. Firstly, although Timo-
saponin B-II can reduce necroptosis by resisting oxidative
stress and reduce pro-inflammatory molecule, but it is im-
possible to recover to normal level, which indicates its
limited function as monomer herbal extraction, it also in-
directly supports the compatibility usage of Chinese herbal
drugs. Secondly, our results showed that higher concen-
trations of Timosaponin B-II (e.g. 1000 μM) could be
toxic. Frank’s research showed Timosaponin B-II and
Timosaponin A-III have the similar structure (such as
steroid), but Timosaponin B-II presents one more glycosyl
[41]. Timosaponin B-II has the trend to convert into
Timosaponin A-III. However higher concentrations of
Timosaponin A-III has been regarded as highly cytotoxic
[41-43] and could cause cell death instead of protective ef-
fect. Therefore, we would consider discarding this concen-
tration (1000 μM) in future studies. Until now, the
molecule of regulation mechanism for cellular necroptosis
upon injury was concerned, including receptor interacting
proteins (RIPs) [8,10,12,13], calpains [14,44], CDGSH
iron-sulfur domain-containing protein 1 (CISD1) [45] or
ubiquitin C-terminal hydrolase (UCH-L1) [46], etc. There-
fore, whether the possible pathway of Timosaponin B-II
neuro-protection may mediate by these molecules men-
tioned above needs further investigation.
Conclusion
Timosaponin B-II with limited concentrations can par-
tially protect RGC-5 from H2O2 induced-necroptosis,
which may related to TNF-α and ROS accumulation
inhibition.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
LS, J-FH and KX designed the experiment. S-HJ, LS and WD performed the
experiment. S-HJ, LS and R-FM drafted the manuscript. SC analyzed the data.
KX revised the manuscript and participated in paper modification. L-XX
revised the manuscript for English writing. All authors participated in critical
revision of the manuscript and approved the final manuscript.
Acknowledgements
This work is supported by National Natural Science Foundation of China
(#81371011), Wu Jie-Ping Medical Foundation of the Minister of Health of
China (320.6750.14118), Natural Science Foundation of Hunan Province
(#2015JJ2187) and Young Teachers Training Program of Normal University of
Hunan Province to KX. We are grateful for the provision of Timosaponin B-II
from Professor Wan-Sheng Chen in Department of Pharmacology, School of
Pharmacology, Second Military Medical University, Shanghai, China.
Author details
1Department of Anatomy and Neurobiology, School of Basic Medical
Science, Central South University, Changsha, Hunan 410013, China.
2Department of Biochemistry and Molecular Biology, Peking University
Health Science Center, Beijing 100191, China. 3Xiangya School of Medicine,
Central South University, Changsha, Hunan 410013, China.
Jiang et al. BMC Complementary and Alternative Medicine 2014, 14:459 Page 8 of 9
http://www.biomedcentral.com/1472-6882/14/459Received: 22 August 2014 Accepted: 26 November 2014
Published: 2 December 2014References
1. Wu W, Liu P, Li J: Necroptosis: an emerging form of programmed cell
death. Crit Rev Oncol Hematol 2012, 82(3):249–258.
2. Han J, Zhong CQ, Zhang DW: Programmed necrosis: backup to and
competitor with apoptosis in the immune system. Nat Immunol 2011,
12(12):1143–1149.
3. Bonnet MC, Preukschat D, Welz PS, van Loo G, Ermolaeva MA, Bloch W,
Haase I, Pasparakis M: The adaptor protein FADD protects epidermal
keratinocytes from necroptosis in vivo and prevents skin inflammation.
Immunity 2011, 35(4):572–582.
4. Song KJ, Jang YS, Lee YA, Kim KA, Lee SK, Shin MH: Reactive oxygen
species-dependent necroptosis in Jurkat T cells induced by pathogenic
free-living Naegleria fowleri. Parasite Immunol 2011, 33(7):390–400.
5. Wu YT, Tan HL, Huang Q, Sun XJ, Zhu X, Shen HM: zVAD-induced
necroptosis in L929 cells depends on autocrine production of TNFalpha
mediated by the PKC-MAPKs-AP-1 pathway. Cell Death Differ 2011,
18(1):26–37.
6. Vanlangenakker N, Bertrand MJ, Bogaert P, Vandenabeele P, Vanden Berghe
T: TNF-induced necroptosis in L929 cells is tightly regulated by multiple
TNFR1 complex I and II members. Cell Death Dis 2011, 2:e230.
7. Jouan-Lanhouet S, Arshad MI, Piquet-Pellorce C, Martin-Chouly C,
Le Moigne-Muller G, Van Herreweghe F, Takahashi N, Sergent O, Lagadic-
Gossmann D, Vandenabeele P, Samson M, Dimanche-Boitrel MT: TRAIL
induces necroptosis involving RIPK1/RIPK3-dependent PARP-1 activation.
Cell Death Differ 2012, 19(12):2003–2014.
8. Vieira M, Fernandes J, Carreto L, Anuncibay-Soto B, Santos M, Han J,
Fernandez-Lopez A, Duarte CB, Carvalho AL, Santos AE: Ischemic insults
induce necroptotic cell death in hippocampal neurons through the
up-regulation of endogenous RIP3. Neurobiol Dis 2014, 68C:26–36.
9. Chen WW, Yu H, Fan HB, Zhang CC, Zhang M, Zhang C, Cheng Y, Kong J,
Liu CF, Geng D, Xu X: RIP1 mediates the protection of geldanamycin on
neuronal injury induced by oxygen-glucose deprivation combined with
zVAD in primary cortical neurons. J Neurochem 2012, 120(1):70–77.
10. Viringipurampeer IA, Shan X, Gregory-Evans K, Zhang JP, Mohammadi Z,
Gregory-Evans CY: Rip3 knockdown rescues photoreceptor cell death in
blind pde6c zebrafish. Cell Death Differ 2014, 21(5):665–675.
11. Rosenbaum DM, Degterev A, David J, Rosenbaum PS, Roth S, Grotta JC,
Cuny GD, Yuan J, Savitz SI: Necroptosis, a novel form of caspase-
independent cell death, contributes to neuronal damage in a retinal
ischemia-reperfusion injury model. J Neurosci Res 2010, 88(7):1569–1576.
12. Dvoriantchikova G, Degterev A, Ivanov D: Retinal ganglion cell (RGC)
programmed necrosis contributes to ischemia-reperfusion-induced ret-
inal damage. Exp Eye Res 2014, 123C:1–7.
13. Huang JF, Shang L, Zhang MQ, Wang H, Chen D, Tong JB, Huang H, Yan
XX, Zeng LP, Xiong K: Differential neuronal expression of receptor
interacting protein 3 in rat retina: involvement in ischemic stress
response. BMC Neurosci 2013, 14:16.
14. Shang L, Huang J-F, Ding W, Chen S, Xue L-X, Ma R-F, Xiong K: Calpain: a
molecule to induce AIF-mediated necroptosis in RGC-5 following
elevated hydrostatic pressure. BMC Neurosci 2014, 15(1):63.
15. Daoud A, Song J, Xiao F, Shang J: B-9-3, a novel beta-carboline derivative
exhibits anti-cancer activity via induction of apoptosis and inhibition of
cell migration in vitro. Eur J Pharmacol 2014, 724:219–230.
16. Choi S, Keys H, Staples RJ, Yuan J, Degterev A, Cuny GD: Optimization of
tricyclic Nec-3 necroptosis inhibitors for in vitro liver microsomal
stability. Bioorg Med Chem Lett 2012, 22(17):5685–5688.
17. Wang K, Li J, Degterev A, Hsu E, Yuan J, Yuan C: Structure-activity
relationship analysis of a novel necroptosis inhibitor, Necrostatin-5.
Bioorg Med Chem Lett 2007, 17(5):1455–1465.
18. Zheng W, Degterev A, Hsu E, Yuan J, Yuan C: Structure-activity relationship
study of a novel necroptosis inhibitor, necrostatin-7. Bioorg Med Chem
Lett 2008, 18(18):4932–4935.
19. Wu Z, Li Y, Cai Y, Yuan J, Yuan C: A novel necroptosis inhibitor-
necrostatin-21 and its SAR study. Bioorg Med Chem Lett 2013,
23(17):4903–4906.
20. Xing J, Yi-fan F: Advances in studies on saponins in Anemarrhena
asphodeloides. Chinese Tradit Herbal Drugs 2010, 41(4):supl12-15.21. Li TJ, Qiu Y, Yang PY, Rui YC, Chen WS: Timosaponin B-II improves memory
and learning dysfunction induced by cerebral ischemia in rats. Neurosci
Lett 2007, 421(2):147–151.
22. Kim JY, Shin JS, Ryu JH, Kim SY, Cho YW, Choi JH, Lee KT: Anti-inflammatory
effect of anemarsaponin B isolated from the rhizomes of Anemarrhena
asphodeloides in LPS-induced RAW 264.7 macrophages is mediated by
negative regulation of the nuclear factor-kappaB and p38 pathways. Food
Chem Toxicol 2009, 47(7):1610–1617.
23. Zhang J, Zhang M, Sugahara K, Sagara Y, Meng Z, Xu S, Kodama H: Effect
of steroidal saponins of Anemarrhenae rhizoma on superoxide
generation in human neutrophils. Biochem Biophys Res Commun 1999,
259(3):636–639.
24. Kaname N, Zhang J, Meng Z, Xu S, Sugahara K, Doi Y, Kodama H: Effect of
timosaponin E1 and E2 on superoxide generation induced by various
stimuli in human neutrophils and on platelet aggregation in human
blood. Clin Chim Acta 2000, 295(1–2):129–140.
25. Yun D, Bai-ping M, Yu-wen C, Yu-xian S, Jing-jing Z, Yu-jun S: Protective
effects of timosaponin BII on primary neurons against beta amyloid
peptide 25–35. Chinese Pharmacol Bull 2009, 02:244–247.
26. Yun D, Qiuping X, Zhenquan L, Baiping M, Chengqi X, Yang Z: Protective
effects of saponin compound from anemarrhena asphodeloides on rat
undergone cerebral ischemia/ reperfusion. J Beijing Univ Tradit Chinese
Med 2005, 02:33–35.
27. Huang JF, Shang L, Liu P, Zhang MQ, Chen S, Chen D, Fan CL, Wang H,
Xiong K: Timosaponin-BII inhibits the up-regulation of BACE1 induced by
ferric chloride in rat retina. BMC Complement Altern Med 2012, 12:189.
28. Li GY, Li T, Fan B, Zheng YC, Ma TH: The D(1) dopamine receptor agonist,
SKF83959, attenuates hydrogen peroxide-induced injury in RGC-5 cells
involving the extracellular signal-regulated kinase/p38 pathways. Mol Vis
2012, 18:2882–2895.
29. Zhang F, Zhan Q, Gao S, Dong X, Jiang B, Sun L, Tao X, Chen WS: Chemical
profile- and pharmacokinetics-based investigation of the synergistic
property of platycodonis radix in traditional Chinese medicine formula
Shengxian decoction. J Ethnopharmacol 2014, 152(3):497–507.
30. Tsai CH, Yang CW, Wang JY, Tsai YF, Tseng LM, King KL, Chen WS, Chiu JH,
Shyr YM: Timosaponin AIII Suppresses Hepatocyte Growth Factor-
Induced Invasive Activity through Sustained ERK Activation in Breast
Cancer MDA-MB-231 Cells. Evid Based Complement Alternat Med 2013,
2013:421051.
31. Laster SM, Wood JG, Gooding LR: Tumor necrosis factor can induce
both apoptic and necrotic forms of cell lysis. J Immunol 1988,
141(8):2629–2634.
32. Liang X, Chen Y, Zhang L, Jiang F, Wang W, Ye Z, Liu S, Yu C, Shi W:
Necroptosis, a novel form of caspase-independent cell death, contributes
to renal epithelial cell damage in an ATP-depleted renal ischemia model.
Mol Med Rep 2014, 10(2):719–724.
33. Lin W, Tongyi S: Role of Bax/Bcl-2 family members in green tea
polyphenol induced necroptosis of p53-deficient Hep3B cells. Tumour
Biol 2014, 35(8):8065–8075.
34. Sawai H: Characterization of TNF-induced caspase-independent
necroptosis. Leuk Res 2014, 38(6):706–713.
35. Lu WQ, Qiu Y, Li TJ, Tao X, Sun LN, Chen WS: Timosaponin B-II inhibits
pro-inflammatory cytokine induction by lipopolysaccharide in BV2 cells.
Arch Pharm Res 2009, 32(9):1301–1308.
36. Miura T, Ichiki H, Iwamoto N, Kato M, Kubo M, Sasaki H, Okada M, Ishida T,
Seino Y, Tanigawa K: Antidiabetic activity of the rhizoma of Anemarrhena
asphodeloides and active components, mangiferin and its glucoside.
Biol Pharm Bull 2001, 24(9):1009–1011.
37. Li Y: The protective effects of TSA after cerebral ischemia in rats. Master Degree.
Beijing: Beijing University of Chinese Medicine; 2010.
38. Guo C, Li L, Yang X, Meng Z, Li F, Zhang C, Yang Z: Protective effects of
timosaponin B-II on high glucose-induced apoptosis in human umbilical
vein endothelial cells. Environ Toxicol Pharmacol 2014, 37(1):37–44.
39. Vandenabeele P, Declercq W, Van Herreweghe F, Vanden Berghe T: The
role of the kinases RIP1 and RIP3 in TNF-induced necrosis. Sci Signal
2010, 3(115):re4.
40. Zhang DW, Zheng M, Zhao J, Li YY, Huang Z, Li Z, Han J: Multiple death
pathways in TNF-treated fibroblasts: RIP3- and RIP1-dependent and
independent routes. Cell Res 2011, 21(2):368–371.
41. King FW, Fong S, Griffin C, Shoemaker M, Staub R, Zhang YL, Cohen I,
Shtivelman E: Timosaponin AIII is preferentially cytotoxic to tumor cells
Jiang et al. BMC Complementary and Alternative Medicine 2014, 14:459 Page 9 of 9
http://www.biomedcentral.com/1472-6882/14/459through inhibition of mTOR and induction of ER stress. PLoS One 2009,
4(9):e7283.
42. Wang N, Feng Y, Zhu M, Siu FM, Ng KM, Che CM: A novel mechanism of
XIAP degradation induced by timosaponin AIII in hepatocellular
carcinoma. Biochim Biophys Acta 2013, 1833(12):2890–2899.
43. Sy LK, Yan SC, Lok CN, Man RY, Che CM: Timosaponin A-III induces autophagy
preceding mitochondria-mediated apoptosis in HeLa cancer cells. Cancer
Res 2008, 68(24):10229–10237.
44. Cabon L, Galan-Malo P, Bouharrour A, Delavallee L, Brunelle-Navas MN,
Lorenzo HK, Gross A, Susin SA: BID regulates AIF-mediated caspase-
independent necroptosis by promoting BAX activation. Cell Death Differ
2012, 19(2):245–256.
45. Shulga N, Pastorino JG: Mitoneet mediates TNFalpha-induced necroptosis
promoted by exposure to fructose and ethanol. J Cell Sci 2014,
127(Pt 4):896–907.
46. Sosna J, Voigt S, Mathieu S, Kabelitz D, Trad A, Janssen O, Meyer-
Schwesinger C, Schutze S, Adam D: The proteases HtrA2/Omi and UCH-L1
regulate TNF-induced necroptosis. Cell Commun Signal 2013, 11:76.
doi:10.1186/1472-6882-14-459
Cite this article as: Jiang et al.: The effect and underlying mechanism of
Timosaponin B-II on RGC-5 necroptosis induced by hydrogen peroxide.
BMC Complementary and Alternative Medicine 2014 14:459.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
